Loss of Cln5 causes altered neurogenesis in a mouse model of a childhood neurodegenerative disorder

Dis Model Mech. 2017 Sep 1;10(9):1089-1100. doi: 10.1242/dmm.029165. Epub 2017 Jul 21.

Abstract

Neural stem/progenitor cells (NPCs) generate new neurons in the brain throughout an individual's lifetime in an intricate process called neurogenesis. Neurogenic alterations are a common feature of several adult-onset neurodegenerative diseases. The neuronal ceroid lipofuscinoses (NCLs) are the most common group of inherited neurodegenerative diseases that mainly affect children. Pathological features of the NCLs include accumulation of lysosomal storage material, neuroinflammation and neuronal degeneration, yet the exact cause of this group of diseases remains poorly understood. The function of the CLN5 protein, causative of the CLN5 disease form of NCL, is unknown. In the present study, we sought to examine neurogenesis in the neurodegenerative disorder caused by loss of Cln5 Our findings demonstrate a newly identified crucial role for CLN5 in neurogenesis. We report for the first time that neurogenesis is increased in Cln5-deficient mice, which model the childhood neurodegenerative disorder caused by loss of Cln5 Our results demonstrate that, in Cln5 deficiency, proliferation of NPCs is increased, NPC migration is reduced and NPC differentiation towards the neuronal lineage is increased concomitantly with functional alterations in the NPCs. Moreover, the observed impairment in neurogenesis is correlated with increased expression of the pro-inflammatory cytokine IL-1β. A full understanding of the pathological mechanisms that lead to disease and the function of the NCL proteins are critical for designing effective therapeutic approaches for this devastating neurodegenerative disorder.

Keywords: Batten disease; CLN5; Lysosomal storage disease; Neurogenesis; Neuronal ceroid lipofuscinoses; Stem cells.

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Calcium / metabolism
  • Cell Differentiation / drug effects
  • Cell Movement / drug effects
  • Cell Proliferation / drug effects
  • Child
  • Disease Models, Animal
  • Hippocampus / metabolism*
  • Hippocampus / pathology*
  • Humans
  • Interleukin-1beta / pharmacology
  • Lysosomal Membrane Proteins
  • Membrane Glycoproteins / deficiency*
  • Membrane Glycoproteins / genetics
  • Membrane Glycoproteins / metabolism
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Neural Stem Cells / drug effects
  • Neural Stem Cells / metabolism
  • Neurogenesis* / drug effects
  • Neuronal Ceroid-Lipofuscinoses / metabolism*
  • Neuronal Ceroid-Lipofuscinoses / pathology*
  • Phenotype
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism

Substances

  • Cln5 protein, mouse
  • Interleukin-1beta
  • Lysosomal Membrane Proteins
  • Membrane Glycoproteins
  • RNA, Messenger
  • Calcium